Form 4: Bicycle Therapeutics COO Sells Shares
Insider Transaction (Form 4)
Jennifer Scott Perry, Chief Operating Officer of Bicycle Therapeutics Plc, sold 1,500 shares of common stock on October 2, 2026.
Summary
- Open-market sale: disposed of 1,094 Ordinary Shares at $3.47 ($3,796) on October 2, 2026; holds 89,958 after (Direct).
- Open-market sale: disposed of 80 Ordinary Shares at $3.56 ($285) on October 5, 2026; holds 89,878 after (Direct).
- Open-market sale: disposed of 326 Ordinary Shares at $3.78 ($1,232) on October 5, 2026; holds 89,552 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $5,313 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jennifer Scott Perry — Officer (Chief Operating Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Open-market sale | Ordinary Shares | 1,094 | $3 | $3.8K | 89,958 |
| 2026-10-05 | Open-market sale | Ordinary Shares | 80 | $4 | $285 | 89,878 |
| 2026-10-05 | Open-market sale | Ordinary Shares | 326 | $4 | $1.2K | 89,552 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Open-market sale (1,094 shares) |
| 2026-10-05 | Open-market sale (80 shares) |
| 2026-10-05 | Open-market sale (326 shares) |
Keywords
insider transaction, Form 4, BCYC, BICYCLE THERAPEUTICS PLC, bearish, Jennifer Scott Perry
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.